The United States of America, as represented by the Secretary, Department of Health and Human Ser

Patent Applications and Registrations

Patent applications and USPTO patent grants for The United States of America, as represented by the Secretary, Department of Health and Human Ser.The latest application filed is for "combination of near infrared photoimmunotherapy targeting cancer cells and host-immune activation".

Company Profile

1.0.17

The United States of America, as represented by the Secretary, Department of Health and Human Ser - Bethesda MD US
The United States of America, as represented by the Secretary, Department of Health and Human Ser.. - Bethesda MD US
THE UNITED STATES OF AMERICAN, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SER - Bethesda MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Near Infrared Photoimmunotherapy Targeting Cancer Cells And Host-immune Activation App 20210079112 - Kobayashi; Hisataka ; et al.	2021-03-18
Denoising Of Dynamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations In The Kinetic Domain App 20200049782 - Brender; Jeffrey R. ; et al.	2020-02-13
Virus-like Particle Conjugates For Diagnosis And Treatment Of Tumors App 20190083647 - de los Pinos; Elisabet ; et al.	2019-03-21
Tumor Infiltrating Lymphocytes And Methods Of Therapy App 20190008899A1 -	2019-01-10
Methods And Compositions For Inducing Protective Immunity Against Filovirus Infection App 20170290904 - VOLKMANN; Ariane ; et al.	2017-10-12
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production App 20170189520 - Collins; Peter L. ; et al.	2017-07-06
Imaging Agents For Imaging Protease Activity And Uses Thereof App 20170143851 - Chen; Xiaoyuan ; et al.	2017-05-25
Anti-viral Cnidarins App 20160333060 - O'Keefe; Barry R. ; et al.	2016-11-17
Cytolethal Distending Toxin Subunit B Conjugated Or Fused To Bacillus Anthracis Toxin Lethal Factor App 20160145590 - Bachran; Christopher H. ; et al.	2016-05-26
Hyposialylation Disorders App 20160025717 - Huizing; Marjan ; et al.	2016-01-28
Coincidence Reporter Gene System App 20160024600 - Inglese; James ; et al.	2016-01-28
Methods Of Producing Enriched Populations Of Tumor-reactive T Cells From Tumor App 20160010058 - Gros; Alena ; et al.	2016-01-14
METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) App 20150368713 - Bharti; Kapil ; et al.	2015-12-24
Assay To Measure Midkine Or Pleiotrophin Level For Diagnosing A Growth App 20150301057 - Baron; Jeffrey ; et al.	2015-10-22
Intralipid As A Contrast Agent To Enhance Subsurface Blood Flow Imaging App 20150209449 - Pan; Yingtian ; et al.	2015-07-30
Compositions And Methods To Treat Cardiac Diseases App 20150038463 - Liang; Bruce ; et al.	2015-02-05
Immunogens Based On An Hiv-1 V1v2 Site-of-vulnerability App 20140348865 - Kwong; Peter ; et al.	2014-11-27
KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCs) App 20130330741 - Hager; Gordon L. ; et al.	2013-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.